Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET
Clinical trial NCT05385861 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05385861
- Sponsor
- National Health Research Institutes, Taiwan
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-14
- Primary completion
- 2025-12-31
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.